DxGen Corp.
PrivateLast Round
Series B
Jan 31, 2019
Total Funding Raised
$5.78M
Company Overview
DxGen Corp. operates in Healthcare & Life Sciences and is based in Gunpo-si. Its latest recorded funding round was a Series B round in January 2019.
DxGen Corp. is a healthcare company that develops and manufactures point-of-care diagnostic analyzers and test kits for diabetes and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DxGen Corp. Comparables
Compare DxGen Corp. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chengdu Seamaty Technology Co., Ltd. | 83% | |
| Roche Holding | 78% | |
| Epinex Diagnostics, Inc. | 77% |
For institutional investors. Book with your work email.
DxGen Corp. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
DxGen Corp. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BNH INVESTMENT | Series A |
| KB Securities | Series B |
| Hana Securities | Series B |
| HB Investment | Series B |
| LSK Investment | Series A |
| Woori Bank | Series B |
| Shinhan Capital Co., Ltd. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
Monthly visitors grew 332% MoM to 3.5K.
- Jan 31, 2019
$3.58M round with KB Securities and HB Investment.
For institutional investors. Book with your work email.
DxGen Corp. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DxGen Corp.'s valuation, stock price, and market status.
Is DxGen Corp. a public or private company?
DxGen Corp. is a private company.
What is the current stock price of DxGen Corp.?
DxGen Corp. is a private company, so its shares have no public market price. Caplight tracks DxGen Corp.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DxGen Corp. worth (valuation)?
Valuation information for DxGen Corp. is not publicly available.
Can I buy DxGen Corp. stock?
DxGen Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DxGen Corp.'s last funding round?
DxGen Corp.'s most recent funding round was Series B on January 31, 2019.
Who are the main investors in DxGen Corp.?
Key investors in DxGen Corp. include BNH INVESTMENT, KB Securities, Hana Securities, HB Investment, LSK Investment.
Will DxGen Corp. IPO soon?
No public IPO plans have been announced for DxGen Corp..
How can I track DxGen Corp. secondary market activity?
Caplight tracks bids, offers, and trades in DxGen Corp.'s shares on secondary markets.